Su H, Shang X, Liu H, Tian M, et al. Low-dose lenvatinib plus toripalimab for patients with platinum-resistant recurrent ovarian cancer: preliminary results from a multicenter, phase II trial (NCT06241105). Gynecol Oncol 2025;199:124-132.
PMID: 40616958